The amelioration of streptozotocin diabetes-induced renal damage by Wu-Ling-San (Hoelen Five Herb Formula), a traditional Chinese prescription

被引:67
作者
Liu, I-Min [1 ,2 ]
Tzeng, Thing-Fong [3 ]
Liou, Shorong-Shii [1 ,2 ]
Chang, Chia Ju [1 ,2 ]
机构
[1] Tajen Univ, Dept Pharm, Yen Pou, Ping Tung Shien, Taiwan
[2] Tajen Univ, Grad Inst Pharmaceut Technol, Yen Pou, Ping Tung Shien, Taiwan
[3] Pao Chien Hosp, Dept Internal Med, Ping Tung City, Taiwan
关键词
Diabetic nephropathy; STZ-diabetic rats; Wu-Ling-San; GLYCATION END-PRODUCTS; OXIDATIVE STRESS; NEPHROPATHY; PEROXIDATION; MECHANISMS; CINNAMON; PREVENT;
D O I
10.1016/j.jep.2009.04.021
中图分类号
Q94 [植物学];
学科分类号
071001 [植物学];
摘要
Ethnopharmacological relevance: Wu-Ling-San (Hoelen Five Herb Formula) is a Chinese prescription used to promote water metabolism. Aim of the study: The present study was undertaken to characterize the effects of Wu-Ling-San on diabetic nephropathy. Materials and methods: Streptozotocin (STZ)-diabetic rats were orally administrated with Wu-Ling-San (0.5, 1.5, 2.5 g/(kg day)) once a day for 10 weeks. Changes in the renal function related parameters in plasma and urine were analyzed at the end of 10-week administration. Kidney was isolated for pathology histology, immunohistochemistry staining and Western blot analyses. Results: Wu-Ling-San (2.5 g/(kg day)) partially decreased the high plasma glucose level in diabetic rats. Diabetic-dependent alterations in urinary albumin, 24-h urinary albumin excretion rate, creatinine clearance, and glomerular mesangial matrix expansion were ameliorated by Wu-Ling-San. The increased expression of nuclear factor-kB as well as transforming growth factor-P I and the progressive accumulation of fibronectin in kidney of diabetic rats were attenuated by Wu-Ling-San. Not only the elevated levels of advanced glycation end products (AGEs) and mitochondrial thiobarbituric acid-reactive substance, but also the higher levels of N-epsilon-(carboxymethyl)lysine and receptor for AGEs in kidney of diabetic rats were ameliorated by Wu-Ling-San. Conclusions: : Wu-Ling-San posses an anti-diabetic property with plasma glucose lowering action accompanied with amelioration of glycation-mediated renal damage. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:211 / 218
页数:8
相关论文
共 30 条
[1]
Isolation and characterization of polyphenol type-A polymers from cinnamon with insulin-like biological activity [J].
Anderson, RA ;
Broadhurst, CL ;
Polansky, MM ;
Schmidt, WF ;
Khan, A ;
Flanagan, VP ;
Schoene, NW ;
Graves, DJ .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2004, 52 (01) :65-70
[2]
The importance of blood pressure control in the patient with diabetes [J].
Bakris, GL .
AMERICAN JOURNAL OF MEDICINE, 2004, 116 :30-38
[3]
SUPPRESSION OF EXPERIMENTAL GLOMERULONEPHRITIS BY ANTISERUM AGAINST TRANSFORMING GROWTH FACTOR-BETA-1 [J].
BORDER, WA ;
OKUDA, S ;
LANGUINO, LR ;
SPORN, MB ;
RUOSLAHTI, E .
NATURE, 1990, 346 (6282) :371-374
[4]
Advanced glycation end products, oxidant stress and vascular lesions [J].
Chappey, O ;
Dosquet, C ;
Wautier, MP ;
Wautier, JL .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1997, 27 (02) :97-108
[5]
Chen DA, 1998, J TRADITIONAL CHINES, V16, P19
[6]
Studies of renal injury III: Lipid-induced nephropathy in type II diabetes [J].
Dominguez, JH ;
Tang, NJ ;
Xu, W ;
Evan, AP ;
Siakotos, AN ;
Agarwal, R ;
Walsh, J ;
Deeg, M ;
Pratt, JH ;
March, KL ;
Monnier, VM ;
Weiss, MF ;
Baynes, JW ;
Peterson, R .
KIDNEY INTERNATIONAL, 2000, 57 (01) :92-104
[7]
POLYANTIGENIC EXPANSION OF BASEMENT-MEMBRANE CONSTITUENTS IN DIABETIC NEPHROPATHY [J].
FALK, RJ ;
SCHEINMAN, JI ;
MAUER, SM ;
MICHAEL, AF .
DIABETES, 1983, 32 :34-39
[8]
The advanced glycation end product, N-(epsilon)(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions [J].
Fu, MX ;
Requena, JR ;
Jenkins, AJ ;
Lyons, TJ ;
Baynes, JW ;
Thorpe, SR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (17) :9982-9986
[9]
ACE-inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathy [J].
Gross, ML ;
El-Shakmak, A ;
Szábó, A ;
Koch, A ;
Kuhlmann, A ;
Münter, K ;
Ritz, E ;
Amann, K .
DIABETOLOGIA, 2003, 46 (06) :856-868
[10]
HATTORI T, 1997, JPN J NEPHROL, V39, P121